Aragen Life Science Pre-IPO Tearsheet

123 Views04 Sep 2026 13:08

Aragen Life Sciences Limited (ALS IN) is looking to raise at least US$300m in its upcoming India IPO. The deal will be run by Axis, Citi, GS, JM Financial.

What is covered in the Full Insight:

Introduction to Aragen Life Sciences
Company Background and Operations
CRO and CDMO Segments
Clientele and Global Reach
Ownership and Shareholders

Hong Jie Seow

SUMMARY

(Sign Up to Access)

Try Now

Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:

Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

SMARTKARMA PREVIEW PASS

By signing up, you agree to our
Terms of Use and Privacy Policy.

Already have an account? Sign In Now

Full Insight

(Paid Plans Only, 3-minute read)

Discussions

(Paid Plans Only)

Price Chart(Sign Up to Access)

Insight Stream

Aragen Life Science Pre-IPO Tearsheet
04 Sep 2026